A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia - Case Reports
- PMID: 33154646
- PMCID: PMC7605965
- DOI: 10.2147/TCRM.S275779
A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia - Case Reports
Abstract
The outbreak of the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) started in China in December 2019. COVID-19 patients at presentation show a wide spectrum of clinical and pathological involvement. We report two cases of respiratory insufficiency due to COVID-19 pneumonia that occurred in adults without a history of respiratory diseases. Although these patients improved and were discharged from the acute ward, during the hospitalization they both progressed with a subsequent clinical and radiological worsening, pointing out one of the main concerns for these patients at discharge: the possibility of developing persistent lung abnormalities also in healthy people not having other risk factors. In conclusion, these cases represent two examples of early lung fibrosis in patients with COVID-19 pneumonia with different severity disease evolution and highlight the need for long-term follow-up strategies. The etiology of this fibrosis is under discussion: we suppose that it could be due to either a possible outcome of natural history of lung damage produced by ARDS, or to the lung injury related to high oxygen level or to the lung damage directly induced by viral infection or finally to the autoimmune response. At this moment, it is not possible to predict how many people will have consequences due to COVID-19 pneumonia, and therefore we believe that careful follow-up should be mandatory.
Keywords: COVID-19; computed tomography; critical care; follow-up; pulmonary fibrosis; viral disease.
© 2020 Scelfo et al.
Conflict of interest statement
The authors report no conflicts of interest for this work.
Figures
Similar articles
-
Three Cases of COVID-19 Pneumonia in Female Patients in Italy Who Had Pulmonary Fibrosis on Follow-Up Lung Computed Tomography Imaging.Am J Case Rep. 2020 Nov 21;21:e926921. doi: 10.12659/AJCR.926921. Am J Case Rep. 2020. PMID: 33219200 Free PMC article.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
-
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Jul 13;21(1):639. doi: 10.1186/s13063-020-04548-z. Trials. 2020. PMID: 32660611 Free PMC article.
-
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.Int J Mol Sci. 2020 Oct 29;21(21):8081. doi: 10.3390/ijms21218081. Int J Mol Sci. 2020. PMID: 33138181 Free PMC article. Review.
-
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?Chin Med J Pulm Crit Care Med. 2023 Jun;1(2):77-83. doi: 10.1016/j.pccm.2022.12.002. Epub 2023 Jan 23. Chin Med J Pulm Crit Care Med. 2023. PMID: 37388822 Free PMC article. Review.
Cited by
-
TMEM176B Prevents and alleviates bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor β-Smad signaling.Heliyon. 2024 Jul 30;10(15):e35444. doi: 10.1016/j.heliyon.2024.e35444. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170226 Free PMC article.
-
Liposomal Forms of Fluoroquinolones and Antifibrotics Decorated with Mannosylated Chitosan for Inhalation Drug Delivery.Pharmaceutics. 2023 Mar 29;15(4):1101. doi: 10.3390/pharmaceutics15041101. Pharmaceutics. 2023. PMID: 37111586 Free PMC article.
-
A Systematic Review of Chest Imaging Findings in Long COVID Patients.J Pers Med. 2023 Feb 1;13(2):282. doi: 10.3390/jpm13020282. J Pers Med. 2023. PMID: 36836515 Free PMC article. Review.
-
Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis.Front Public Health. 2022 Sep 20;10:967829. doi: 10.3389/fpubh.2022.967829. eCollection 2022. Front Public Health. 2022. PMID: 36203683 Free PMC article.
-
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review.Front Pharmacol. 2022 Mar 4;13:748931. doi: 10.3389/fphar.2022.748931. eCollection 2022. Front Pharmacol. 2022. PMID: 35308222 Free PMC article. Review.
References
-
- World Health Organization. WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim Guidance. 2020.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous